Name | 4-[3-[4-(2-methylimidazol-1-yl)phenyl]sulfanylphenyl]oxane-4-carboxamide |
---|---|
Synonyms | Tetrahydro-4-[3-[[4-(2-methyl-1H-imidazol-1-yl)phenyl]thio]phenyl]-2H-pyran-4-carboxamide |
Description | CJ-13,610, a nonredox-type 5-LO inhibitor, dose dependently suppresses 5-LO product formation in ionophore A23187-stimulated PMNL in the absence of exogenous AA with an IC50 of about 70 nM[1]. PMNL: polymorphonuclear leukocytes; AA: arachidonic acid |
---|---|
Related Catalog | |
References |
Melting Point | 198 - 200 °C |
---|---|
Molecular Formula | C22H23N3O2S |
Molecular Weight | 393.50200 |
Exact Mass | 393.15100 |
PSA | 96.43000 |
LogP | 5.01510 |
Storage condition | 2-8°C |
RIDADR | NONH for all modes of transport |
---|